Abstract |
In this Letter, we presented in vitro studies of antimicrobial activity of Gly-His-Lys conjugates that are important point in preliminary biological evaluation of their potential application in skin and tissue therapies. The novel compounds include the conjugation of fatty acids with a modification of the amino acid sequence in the primary structure of Gly-His-Lys (6i). All the compounds exhibited strong to moderate activity. Compound 1d had the most potent antimicrobial activity at MIC ranges 31.3-125.0μg/mL (against Escherichia coli spp. and Staphylococcus aureus spp.), 375.0-500.0μg/mL (against Pseudomonas aeruginosa spp.). Conjugate 5b expressed activity against Staphylococcus aureus spp. and Escherichia coli spp. at MIC ranges 250.0-500.0μg/mL and 62.5-125.0μg/mL, respectively. Both conjugates 1d and 5b possessed rapid bactericidal activity against Gram-positive bacteria at 2MIC or 4MIC. Conjugates 1b-c, 1e, 2a-b and 4b showed noticeable effect against both Gram-positive and Gram-negative bacteria. Compounds 1d, 1e and 2e were the most active against fungus.
|
Authors | Monika Kukowska, Magdalena Kukowska-Kaszuba, Krystyna Dzierzbicka |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 25
Issue 3
Pg. 542-6
(Feb 01 2015)
ISSN: 1464-3405 [Electronic] England |
PMID | 25556094
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Ltd. All rights reserved. |
Chemical References |
- Anti-Infective Agents
- Oligopeptides
- glycyl-histidyl-lysine
|
Topics |
- Anti-Infective Agents
(chemical synthesis, pharmacology, therapeutic use)
- Bacteremia
(drug therapy, microbiology)
- Escherichia coli
(drug effects)
- Fungi
(drug effects)
- Humans
- Microbial Sensitivity Tests
- Oligopeptides
(chemistry)
- Pseudomonas aeruginosa
(drug effects)
- Skin Diseases, Bacterial
(drug therapy, microbiology)
- Staphylococcus aureus
(drug effects)
|